Milbank Advising Financing Sources on EQT-led Consortium’s £4.6B Recommended Cash Offer for Dechra Pharma Plc

Milbank LLP is advising a group of 10 private credit funds on the £1.25 billion financing for EQT’s £4.6 billion cash offer to acquire Dechra Pharma plc, in what would be one of the biggest UK takeover deals this year.

Dechra is a global specialist in veterinary pharmaceuticals and related products business, whose expertise is in the development, manufacture, marketing and sales of high-quality products exclusively for veterinarians worldwide.

The Milbank team is led by European Leveraged Finance/Capital Markets partners Suhrud Mehta, Alexandra Grant and Laura Bonamis, associates Michael Gatter, Bie Cookey, Christopher Smith, Suktika Banerjee, Pranahita Srinivas and Yalini Ravi; Global Corporate partner Andrej Wolf, special counsel Merih Altay and associate Kate Meils.